390 related articles for article (PubMed ID: 29902448)
1. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic plasma exchange and intravenous immunoglobulin as primary therapy for D alloimmunization in pregnancy precludes the need for intrauterine transfusion.
Bellone M; Boctor FN
Transfusion; 2014 Aug; 54(8):2118-21. PubMed ID: 24673470
[TBL] [Abstract][Full Text] [Related]
3. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation.
Lindenburg IT; van Kamp IL; van Zwet EW; Middeldorp JM; Klumper FJ; Oepkes D
BJOG; 2013 Jun; 120(7):847-52. PubMed ID: 23551577
[TBL] [Abstract][Full Text] [Related]
4. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
[TBL] [Abstract][Full Text] [Related]
5. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
Houston BL; Govia R; Abou-Setta AM; Reid GJ; Hadfield M; Menard C; Noyd J; Main S; Zarychanski R
Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100
[TBL] [Abstract][Full Text] [Related]
6. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
Mimura K; Endo M; Takahashi A; Doi Y; Sakuragi M; Kiyokawa T; Taniguchi H; Kitabatake Y; Handa M; Tomimatsu T; Tomiyama Y; Isaka Y; Kimura T
Int J Hematol; 2020 Jan; 111(1):149-154. PubMed ID: 31538326
[TBL] [Abstract][Full Text] [Related]
7. Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease.
Kriplani A; Malhotra Singh B; Mandal K
Gynecol Obstet Invest; 2007; 63(3):176-80. PubMed ID: 17143009
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.
Sainio S; Nupponen I; Kuosmanen M; Aitokallio-Tallberg A; Ekholm E; Halmesmäki E; Orden MR; Palo P; Raudaskoski T; Tekay A; Tuimala J; Uotila J; Stefanovic V
Acta Obstet Gynecol Scand; 2015 Apr; 94(4):383-90. PubMed ID: 25603954
[TBL] [Abstract][Full Text] [Related]
9. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion.
Fox C; Martin W; Somerset DA; Thompson PJ; Kilby MD
Fetal Diagn Ther; 2008; 23(2):159-63. PubMed ID: 18046076
[TBL] [Abstract][Full Text] [Related]
10. Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment.
Weiner CP; Williamson RA; Wenstrom KD; Sipes SL; Widness JA; Grant SS; Estle L
Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1302-7. PubMed ID: 1957851
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.
Santos MC; Sá C; Gomes SC; Camacho LA; Moreira ME
Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis.
Mustafa HJ; Sambatur EV; Pagani G; D'Antonio F; Maisonneuve E; Maurice P; Zwiers C; Verweij JEJT; Flood A; Shamshirsaz AA; Jouannic JM; Khalil A
Am J Obstet Gynecol; 2024 Apr; ():. PubMed ID: 38588966
[TBL] [Abstract][Full Text] [Related]
13. Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn - review on current management and outcome.
Zwiers C; van Kamp I; Oepkes D; Lopriore E
Expert Rev Hematol; 2017 Apr; 10(4):337-344. PubMed ID: 28277805
[TBL] [Abstract][Full Text] [Related]
14. Successful management of severe Kell alloimmunization in pregnancy with intravenous immune globulin.
Patris M; Holoye A; Goldman D; De Coninck C; Colard M
Transfus Apher Sci; 2024 Apr; 63(2):103868. PubMed ID: 38238203
[TBL] [Abstract][Full Text] [Related]
15. Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis.
Snelgrove JW; D'Souza R; Seaward PGR; Windrim R; Kelly EN; Ryan G
Fetal Diagn Ther; 2019; 46(6):425-432. PubMed ID: 31195389
[TBL] [Abstract][Full Text] [Related]
16. Intravenous fetal exchange transfusion before 22 weeks of gestation in early and severe red-cell fetomaternal alloimmunization.
Poissonnier MH; Picone O; Brossard Y; Lepercq J
Fetal Diagn Ther; 2003; 18(6):467-71. PubMed ID: 14564122
[TBL] [Abstract][Full Text] [Related]
17. Treatment of D alloimmunization in pregnancy with plasmapheresis and intravenous immune globulin: case report.
Fernández Alba JJ; León R; González-Macías C; Paz A; Prado F; Moreno LJ; Torrejón R
Transfus Apher Sci; 2014 Aug; 51(1):70-2. PubMed ID: 25312036
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study.
Maisonneuve E; Dugas A; Friszer S; Toly-Ndour C; Cariot L; Dhombres F; Cortey A; Mailloux A; Carbonne B; Jouannic JM
J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102119. PubMed ID: 33741541
[TBL] [Abstract][Full Text] [Related]
19. Treatment options for the fetus with alloimmune hemolytic disease.
Bowman JM
Transfus Med Rev; 1990 Jul; 4(3):191-207. PubMed ID: 2134630
[No Abstract] [Full Text] [Related]
20. [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995].
van Kamp IL; Klumper FJ; Meerman RH; Brand A; Bennebroek Gravenhorst J; Kanhai HH
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2527-31. PubMed ID: 10627756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
